The Irak-M protein change intervention helps prevent the development of intestinal inflammation and colon cancer

A new study shows that the intervention, changing the shape of a protein called Irak-M in the body can significantly reduce the development of inflammatory bowel disease and colon cancer. Currently the information is causing a stir among the medical world.

A new study shows that the intervention, changing the shape of a protein called Irak-M in the body can significantly reduce the development of inflammatory bowel disease and colon cancer. Currently the information is causing a stir among the medical world.

According to Wasington, US medical researchers, changing the shape and structure of a new protein in the body called Irak-M, a protein that controls inflammatory reactions, can reduce Significant development of two inflammatory bowel diseases as well as colon cancer.

The Irak-M protein change intervention helps prevent the development of intestinal inflammation and colon cancer Picture 1The Irak-M protein change intervention helps prevent the development of intestinal inflammation and colon cancer Picture 1

' When we took the initiative to test the shape and shape of the Irak-M protein structure in mice, the results showed that the mice were less likely to develop inflammatory bowel disease or bowel cancer, preventing the risk. spread and develop the two diseases, "Coy Allen from Virginia-Maryland Veterinary University said in a statement.  

The Irak-M protein change intervention helps prevent the development of intestinal inflammation and colon cancer Picture 2The Irak-M protein change intervention helps prevent the development of intestinal inflammation and colon cancer Picture 2

The team is continuing to evaluate, further research on the human body in collaboration with Duke's Carilion Clinic and Duke University.

However, a preliminary explanation of the conclusion, the team pointed out, the protein Irak-M is a protein that controls inflammation in the body. Any change in the structural shape of this protein also causes its anti-inflammatory ability to change, at least much stronger than normal.

' The explanation above shows that this is one of the most favorable prerequisites and hopes it will contribute to therapeutic supportive therapies for patients with colitis and colon cancer '. The team concluded.

This research has just been published in eBioMedicine magazine.

5 ★ | 1 Vote